Skip to main content
Only goal: Enable you next research experiment
ENZOLIFE SCIENCES

AMPIPROBE® Nucleic Acid Detection

AMPIPROBE® Nucleic Acid Detection

Home Basic Research Technology Platforms Genomic Analysis PCR AMPIPROBE® Nucleic Acid Detection

Home Basic Research Technology Platforms Genomic Analysis PCR AMPIPROBE® Nucleic Acid Detection

Enzo’s mission is to provide low-cost alternative solutions to the diagnostic market. Our AMPIPROBE® platform uses novel PCR design to enable the quantification of nucleic acids for clinically relevant targets. Incorporating our IP into the AMPIPROBE® assays allows Enzo to offer a low-cost option for nucleic acid detection in a price sensitive market.AMPIPROBE® assays are easily adaptable for laboratory use and cost-effective, without compromising on quality and performance. Compatible on open PCR platforms, AMPIPROBE® assays can be validated on existing instrumentation, eliminating the need for capital expenditures.

AMPIPROBE® is a proprietary technology that incorporates probe detection in primer design. It employs a combination of fluorescent reporter-labeled primers and quencher-labeled primers to amplify DNA, akin to traditional qPCR.

A Low-Cost AlternativeFor Nucleic Acid Detection

When free in solution, fluorescent primers generate a signal. However, as the primers are incorporated into amplified DNA, the quencher and the fluorophore are brought within close proximity and exhibit Forster resonance energy transfer (FRET). This causes a logarithmic decay of signal with respect to the number of amplification cycles of DNA.

Genomic AnalysisEnzo Life Sciences

Key Features & Applications

  • Clinical Specificity: 99.3%
  • Size: 96 tests
  • Adaptable to both automated open platforms (including GENFLEX®) and manual processing
  • Sensitive quantitation of HCV viral loadLOD Serum = 5.5 IU/mL
  • LOD Plasma = 7.9 IU/mL
  • Low-cost alternative to other methods of viral load detection
  • Compatible with most open qPCR platforms
  • Complete set of controls including:High, Medium and Low quantitation controls
  • Internal sample extraction control
  • Negative sample control
  • Smaller sample input allows remaining extracted samples to be used in other tests

Enzo’s AMPIPROBE® Technology

Once the signal decays to a defined threshold, a value is generated with respect to the corresponding cycle. The threshold cycle is indicative of the amount of target RNA or DNA in the sample.

AMPIPROBE® SARS-CoV-2 Test System (RUO)

The AMPIPROBE® HCV assay kit is Enzo’s landmark AMPIPROBE® assay for the quantitation of HCV viral load. It has been validated and approved by the New York State Department of Health to be used as a laboratory developed test to quantitatively measure HCV viral load.

AMPIPROBE® Women’s Health Pane

Our AMPIPROBE® SARS-CoV-2 Assay Kit (RUO) is a multiplexed assay designed for the detection of the SARS-CoV-2 virus. It contains two primer/probe sets specific to different SARS-CoV-2 genomic regions and primers/probes for internal control and negative control, human RNase P. This kit is intended to be used in combination with general RNA extraction kits, including AMPIXTRACT™ SARS-CoV-2 Extraction Kit (RUO) and generic qPCR instruments. This assay can also be used in manual settings or with open automated platforms such as the GENFLEX® Automated Instrument (please contact us for more information) or any other open platforms available on the market for the liquid handling process of RNA extraction and PCR set up.

Explore AMPIPROBE® Nucleic Acid Detection - Enzo Solutions

Contact our scientific team to discuss your ampiprobe® nucleic acid detection - enzo needs or find the right products for your research.

Join & Get 15% Off

Sign up for exclusive offers, original stories, events and more.

Learn more →